Jairath V, Yarur A, Osterman MT, James A, et al. ENTERPRET: a randomized controlled trial of vedolizumab dose optimization in patients with ulcerative colitis who have early nonresponse. Clin Gastroenterol Hepatol 2023 Nov 9:S1542-3565(23)00912.
PMID: 37951560